CVS Health Corporation
CVS Health Reports Q1 2025 Results and Updates Guidance
Summary
CVS Health Corporation reported a strong first quarter of 2025, with total revenues increasing by 7.0% to $94.6 billion. The company posted GAAP diluted EPS of $1.41 and Adjusted EPS of $2.25. CVS Health also updated its full-year 2025 guidance, raising its Adjusted EPS range to $6.00 to $6.20 and its cash flow from operations guidance to approximately $7.0 billion. The company highlighted improved performance across its Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.
Profitelligence Alerts
Get alerts for CVS
Be first to know when CVS Health Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Official SEC Documents
Advertisement